- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Obstructive Lung Disease
Total 380977 results
-
Minneapolis Veterans Affairs Medical CenterCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
NovartisCompletedChronic Obstructive Pulmonary Disease (COPD)France, Germany, Belgium, Spain, Turkey, Italy, Canada, Australia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic Obstructive | Chronic Obstructive Pulmonary Disease (COPD)Germany
-
NovartisCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Spain, Turkey, France, Netherlands, Germany
-
Strados Labs, Inc.WithdrawnChronic Obstructive Pulmonary Disease (COPD)United States
-
Pulmatrix Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Chiesi Farmaceutici S.p.A.CompletedCOPD (Chronic Obstructive Pulmonary Disease)China, Korea, Republic of, Taiwan
-
Hannover Medical SchoolCAPNETZ StiftungCompletedChronic Obstructive Pulmonary Disease (COPD)Germany
-
University of AarhusCompletedChronic Obstructive Pulmonary Disease, COPDDenmark
-
Barcelona Institute for Global HealthKU Leuven; University Medical Center Groningen; University of Athens; University... and other collaboratorsCompletedChronic Obstructive Pulmonary Disease (COPD)Netherlands, Greece, Belgium, United Kingdom
-
Novartis PharmaceuticalsWithdrawnChronic Obstructive Pulmonary Disease (COPD)
-
Novartis PharmaceuticalsWithdrawnChronic Obstructive Pulmonary Disease (COPD)
-
Memorial Hospital of Rhode IslandNational Heart, Lung, and Blood Institute (NHLBI)CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Norwegian University of Science and TechnologyCompletedChronic Obstructive Pulmonary Disease (COPD)Norway
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Brazil
-
AstraZenecaMitsubishi Tanabe Pharma CorporationCompletedChronic Obstructive Pulmonary Disease (COPD)Japan
-
University of PennsylvaniaTerminatedChronic Obstructive Pulmonary Disease (COPD)United States
-
Chest Hospital, Ministry of Health and Welfare,...CompletedChronic Obstructive Pulmonary Disease (COPD)Taiwan
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)China, Philippines, Korea, Republic of, India
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Romania, Ukraine, Denmark, Netherlands, Canada
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Japan
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Colombia, Argentina, Germany, Spain, Turkey, Guatemala, Mexico, Australia, Denmark, South Africa, Philippines
-
NovartisCompletedChronic Obstructive Pulmonary Disease (COPD)Spain, Germany, South Africa, Australia, Poland, New Zealand, Netherlands
-
University of Sao PauloCompletedChronic Obstructive Pulmonary Disease (COPD)Brazil
-
King's College Hospital NHS TrustUniversity of BrightonCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
AstraZenecaCompletedLung Diseases | Pulmonary Disease | COPD | COPD Exacerbation | Respiratory Disorders | Chronic Obstructive Airway Disease | Chronic Obstructive Lung DiseasesUnited States, Argentina, Canada, Chile, Colombia, Italy, Malaysia, Mexico, Peru, Philippines, Romania, Russian Federation, Serbia, Spain, Taiwan, Thailand, Ukraine
-
St. Joseph's Healthcare HamiltonBoeringer IngelheimRecruiting
-
Nuvaira, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)France, Belgium, Netherlands, Austria, Germany, United Kingdom
-
University Hospital, BordeauxCompletedChronic Obstructive Pulmonary Disease (COPD)France
-
University of Erlangen-NürnbergBad Reichenhall Clinic, Center for Rehabilitation, Pulmonology and Orthopedics and other collaboratorsCompletedChronic Obstructive Pulmonary Disease (COPD)Germany
-
Queen's UniversityAstraZenecaCompleted
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Belgium, Poland, Romania, Croatia, Estonia, Netherlands, Slovakia, Latvia, Lithuania, United Kingdom, Argentina, Bulgaria, Serbia, Austria, Hungary, Spain, Greece, Canada, Denmark, Czechia
-
Hasselt UniversityJessa HospitalCompletedChronic Obstructive Pulmonary Disease (COPD)Belgium
-
Pneumacare LtdCambridge University Hospitals NHS Foundation TrustUnknownChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
Rush University Medical CenterWithdrawnChronic Obstructive Pulmonary Disease (COPD)
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Slovakia
-
CHU de ReimsCompleted
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Colombia, India, Korea, Republic of, Poland, Romania, South Africa, Italy, Austria, Belgium, Croatia, Estonia, Hungary, Russian Federation, Taiwan, Turkey, Japan, Spain, Sweden, United Kingdom, China, Thailand, Canada, Hong Kong and more
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI); United BioSource, LLCCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
West Park Healthcare CentreCompletedChronic Obstructive Pulmonary Disease (COPD)Canada
-
University of Science Ho Chi Minh CityVan Hanh General Hospital; Nguyen Tri Phuong Hospital, Ho Chi Minh city, Viet... and other collaboratorsUnknown
-
Kwong Wah HospitalCompleted
-
Novartis PharmaceuticalsCompletedCOPDSpain, Germany, Belgium, Poland, South Africa, Australia, Greece, Israel, Sweden, Hong Kong, Thailand, Bulgaria, Singapore, Denmark, Finland, Hungary, Romania, Malaysia
-
Novartis PharmaceuticalsCompleted
-
Hospital de MataróCompleted